Eir Partners has acquired Accumulus Technologies, according to a news release. The transaction was announced as part of Healthcare Investor's private equity deal tracker, which follows healthcare and life sciences investment activity.
Accumulus, founded in 2025 as a spinout of Accumulus Synergy and based in San Francisco, is a software-as-a-service company. Its cloud platform enables life sciences organizations and global regulatory authorities to exchange data and collaborate on submissions, a process that is central to drug development and regulatory review.
Eir, founded in 2015 and based in Miami, is a middle market private equity firm focused on healthcare technology and tech-enabled services. The firm's targeted stages of investment include growth equity through control buyouts, with investment sizes ranging from $40 million to $150 million.
Terms of the transaction were not disclosed. The deal adds Accumulus to Eir's healthcare technology portfolio and underscores continued private equity interest in software that supports regulatory and clinical workflows in the life sciences sector.
Source: Healthcare Investor · Summarized by HeadlinesBriefing